These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28694256)

  • 1. Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development.
    Ahn Y; Sims C; Murray MJ; Kuhlmann PK; Fuentes-Antrás J; Weatherbee SD; Krumlauf R
    Development; 2017 Aug; 144(15):2824-2836. PubMed ID: 28694256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.
    Ahn Y; Sims C; Logue JM; Weatherbee SD; Krumlauf R
    Development; 2013 Feb; 140(3):583-93. PubMed ID: 23293290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
    Choi HY; Dieckmann M; Herz J; Niemeier A
    PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
    Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
    Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning.
    Ahn Y; Sanderson BW; Klein OD; Krumlauf R
    Development; 2010 Oct; 137(19):3221-31. PubMed ID: 20724449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
    Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
    Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lrp4 modulates extracellular integration of cell signaling pathways in development.
    Ohazama A; Johnson EB; Ota MS; Choi HY; Porntaveetus T; Oommen S; Itoh N; Eto K; Gritli-Linde A; Herz J; Sharpe PT
    PLoS One; 2008; 3(12):e4092. PubMed ID: 19116665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin/Receptor Related Protein 4 and Ginkgo Biloba Extract Alleviates β-Glycerophosphate-Induced Vascular Smooth Muscle Cell Calcification By Inhibiting Wnt/β-Catenin Pathway.
    Wang J; Qiu X; Xu T; Sheng Z; Yao L
    Blood Purif; 2019; 47 Suppl 1(Suppl 1):17-23. PubMed ID: 30699436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2
    Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K
    Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRP4 induces extracellular matrix productions and facilitates chondrocyte differentiation.
    Asai N; Ohkawara B; Ito M; Masuda A; Ishiguro N; Ohno K
    Biochem Biophys Res Commun; 2014 Aug; 451(2):302-7. PubMed ID: 25091481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity for an inactivating mutation in low-density lipoprotein-related receptor 6 (Lrp6) increases osteoarthritis severity in mice after ligament and meniscus injury.
    Joiner DM; Less KD; Van Wieren EM; Hess D; Williams BO
    Osteoarthritis Cartilage; 2013 Oct; 21(10):1576-85. PubMed ID: 23756208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lrp4: A novel modulator of extracellular signaling in craniofacial organogenesis.
    Ohazama A; Porntaveetus T; Ota MS; Herz J; Sharpe PT
    Am J Med Genet A; 2010 Dec; 152A(12):2974-83. PubMed ID: 21108386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
    Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
    Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation.
    Lettini G; Condelli V; Pietrafesa M; Crispo F; Zoppoli P; Maddalena F; Laurenzana I; Sgambato A; Esposito F; Landriscina M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt-β-catenin signaling pathway inhibition by sclerostin may protect against degradation in healthy but not osteoarthritic cartilage.
    Wu J; Ma L; Wu L; Jin Q
    Mol Med Rep; 2017 May; 15(5):2423-2432. PubMed ID: 28259981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
    Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
    J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression.
    Nam JS; Turcotte TJ; Smith PF; Choi S; Yoon JK
    J Biol Chem; 2006 May; 281(19):13247-13257. PubMed ID: 16543246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
    Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
    J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.